Mitochondrial, metabolic and bioenergetic adaptations drive plasticity of colorectal cancer cells and shape their chemosensitivity
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Mitochondrial differences in colorectal cancer (CRC) cells suggest varied strategies for survival. Targeting metabolic pathways shows efficacy based on cellular respiration and glycolysis levels, offering new therapeutic avenues.
Area Of Science
- Cell Biology
- Cancer Metabolism
- Mitochondrial Biology
Background
- Mitochondria are crucial for cancer cell metabolic reprogramming, supporting growth and survival.
- The heterogeneity of mitochondria and their specific archetypes in cancer remain largely uncharacterized.
- Understanding these mitochondrial roles is key to developing effective cancer therapies.
Purpose Of The Study
- To investigate mitochondrial heterogeneity and functional specialization in colorectal cancer (CRC) cell lines.
- To identify distinct bioenergetic and mitochondrial phenotypes in CRC cells.
- To explore the relationship between cellular bioenergetics, mitochondrial status, and therapeutic response in CRC.
Main Methods
- Analysis of mitochondrial composition across a panel of CRC cell lines.
- Differentiation of bioenergetic and mitochondrial phenotypes.
- Assessment of treatment efficacy based on cellular respiration and glycolysis levels.
- Identification of key metabolites linked to bioenergetic profiles and treatment responses.
Main Results
- Extensive differences in mitochondrial composition were observed, indicating functional specialization.
- Distinct bioenergetic and mitochondrial phenotypes were identified, reflecting varied CRC cell sustainability strategies.
- Treatment efficacy against metabolic pathways varied significantly based on cancer cell respiration and glycolysis.
- Specific metabolites were identified as predictors of therapeutic efficacy and metabolic vulnerabilities in CRC.
Conclusions
- Colorectal cancer cell populations exhibit significant mitochondrial heterogeneity.
- Cellular bioenergetics and mitochondrial status are critical determinants of CRC therapy effectiveness.
- Metabolite profiling can predict treatment outcomes and reveal metabolic vulnerabilities for targeted therapies.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...